Roth Capital Maintains Buy on 908 Devices, Raises Price Target to $13

Benzinga Newsdesk www.benzinga.com Positive 51.9%

Neg 0% Neu 0% Pos 51.9%

Roth Capital analyst Max Masucci maintains 908 Devices (NASDAQ:MASS) with a Buy and raises the price target from $11 to $13.